Pono Capital Two Wins 9-Month Extension on SBC Medical Deal as Redemptions Continue to Erode Cash in Trust

Pono Capital Two in a regulatory filing said its shareholders approved a deadline extension from Feb. 9 up to Nov. 9.

The SPAC’s stockholders redeemed 273,334 shares, leaving approximately $17.9 million in trust, according to the filing.

The SPAC has a deal with SBC Medical Group, announced a year ago at a $1.2 billion valuation, later reduced to $1 billion.

Tokyo-based SBC Medical Group specializes in medical care and special treatment including cosmetic surgery, infertility, dental, and orthopedics.

Pono Capital Two last May had reported 88% redemptions on an extension vote, leaving about $20 million in the SPAC’s trust at that time. Following that extension vote and redemptions, Mehana Capital, the sponsor, converted 2,874,999 Class B shares into an identical number of Class A shares. That gave Pono Two 5,489,624 shares of outstanding Class A stock, of which 3,566,874 shares are held by the founders and not subject to redemption.

There is no minimum cash consideration to close the SBC Medical deal. Read more.

Related Posts
Read More

DeSPAC Rubicon Technologies Going Private

Rubicon, a digital marketplace for waste and recycling and provider of software-based products for businesses and governments, went public in August 2022 via a business combination with Founder SPAC. The stock has plunged 92% in the last year.